

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | virion attachment to host cell (GO:0019062) | 5.66850830 |
| 2 | adhesion of symbiont to host cell (GO:0044650) | 5.66850830 |
| 3 | cellular extravasation (GO:0045123) | 5.54188449 |
| 4 | adhesion of symbiont to host (GO:0044406) | 4.61808386 |
| 5 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.43462305 |
| 6 | positive regulation of mast cell activation (GO:0033005) | 4.37307264 |
| 7 | activated T cell proliferation (GO:0050798) | 4.14782761 |
| 8 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.10800485 |
| 9 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.77035643 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.75455110 |
| 11 | positive regulation of mast cell degranulation (GO:0043306) | 3.69000987 |
| 12 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.69000987 |
| 13 | regulation of mast cell activation (GO:0033003) | 3.46625601 |
| 14 | regulation of memory T cell differentiation (GO:0043380) | 3.36303695 |
| 15 | platelet dense granule organization (GO:0060155) | 3.35378358 |
| 16 | positive regulation of antigen processing and presentation (GO:0002579) | 3.32950803 |
| 17 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.30716414 |
| 18 | regulation of hypersensitivity (GO:0002883) | 3.29944178 |
| 19 | eosinophil chemotaxis (GO:0048245) | 3.23018982 |
| 20 | tryptophan catabolic process (GO:0006569) | 3.20944500 |
| 21 | indole-containing compound catabolic process (GO:0042436) | 3.20944500 |
| 22 | indolalkylamine catabolic process (GO:0046218) | 3.20944500 |
| 23 | glycosphingolipid catabolic process (GO:0046479) | 3.17919969 |
| 24 | kynurenine metabolic process (GO:0070189) | 3.16013931 |
| 25 | wound healing, spreading of epidermal cells (GO:0035313) | 3.05880799 |
| 26 | positive regulation of B cell differentiation (GO:0045579) | 2.98768986 |
| 27 | neutrophil activation involved in immune response (GO:0002283) | 2.95386200 |
| 28 | superoxide anion generation (GO:0042554) | 2.92025612 |
| 29 | ceramide catabolic process (GO:0046514) | 2.89824350 |
| 30 | T-helper 1 type immune response (GO:0042088) | 2.88146789 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 2.87552693 |
| 32 | eosinophil migration (GO:0072677) | 2.87162516 |
| 33 | behavioral response to nicotine (GO:0035095) | 2.86266786 |
| 34 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.85915766 |
| 35 | regulation of cholesterol storage (GO:0010885) | 2.85644905 |
| 36 | regulation of sequestering of triglyceride (GO:0010889) | 2.85462518 |
| 37 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.83276776 |
| 38 | glycolipid catabolic process (GO:0019377) | 2.82151287 |
| 39 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.80952781 |
| 40 | response to xenobiotic stimulus (GO:0009410) | 2.70337273 |
| 41 | regulation of antigen processing and presentation (GO:0002577) | 2.70170977 |
| 42 | intracellular pH reduction (GO:0051452) | 2.68557196 |
| 43 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.65821541 |
| 44 | regulation of gamma-delta T cell activation (GO:0046643) | 2.64741897 |
| 45 | positive regulation of bone resorption (GO:0045780) | 2.62256656 |
| 46 | positive regulation of bone remodeling (GO:0046852) | 2.62256656 |
| 47 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.59953518 |
| 48 | positive regulation of defense response to virus by host (GO:0002230) | 2.56333281 |
| 49 | negative regulation of mast cell activation (GO:0033004) | 2.56291284 |
| 50 | cellular biogenic amine catabolic process (GO:0042402) | 2.55166906 |
| 51 | amine catabolic process (GO:0009310) | 2.55166906 |
| 52 | tryptophan metabolic process (GO:0006568) | 2.54933214 |
| 53 | negative regulation of interleukin-17 production (GO:0032700) | 2.54653716 |
| 54 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.53312391 |
| 55 | lipoxygenase pathway (GO:0019372) | 2.52514402 |
| 56 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.52293736 |
| 57 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.51630472 |
| 58 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.50663662 |
| 59 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.50207447 |
| 60 | phagosome maturation (GO:0090382) | 2.49332573 |
| 61 | cellular response to ethanol (GO:0071361) | 2.47955487 |
| 62 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.46594594 |
| 63 | L-fucose catabolic process (GO:0042355) | 2.46162830 |
| 64 | fucose catabolic process (GO:0019317) | 2.46162830 |
| 65 | L-fucose metabolic process (GO:0042354) | 2.46162830 |
| 66 | positive regulation of osteoclast differentiation (GO:0045672) | 2.45889616 |
| 67 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.43546930 |
| 68 | negative regulation of interleukin-12 production (GO:0032695) | 2.43152900 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 2.43110391 |
| 70 | positive regulation of tissue remodeling (GO:0034105) | 2.41961226 |
| 71 | positive regulation of prostaglandin secretion (GO:0032308) | 2.38509451 |
| 72 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.38240837 |
| 73 | negative regulation of adaptive immune response (GO:0002820) | 2.35907159 |
| 74 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.35845950 |
| 75 | cellular response to exogenous dsRNA (GO:0071360) | 2.35382180 |
| 76 | regulation of T-helper 1 type immune response (GO:0002825) | 2.33381948 |
| 77 | pH reduction (GO:0045851) | 2.33134557 |
| 78 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.31899515 |
| 79 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.31262592 |
| 80 | regulation of T-helper cell differentiation (GO:0045622) | 2.30798381 |
| 81 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.30789291 |
| 82 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.30082181 |
| 83 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.30082181 |
| 84 | macrophage activation involved in immune response (GO:0002281) | 2.29159022 |
| 85 | negative regulation of macrophage differentiation (GO:0045650) | 2.28429734 |
| 86 | signal peptide processing (GO:0006465) | 2.28169515 |
| 87 | response to lipoprotein particle (GO:0055094) | 2.27924862 |
| 88 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.27888426 |
| 89 | granulocyte chemotaxis (GO:0071621) | 2.27651316 |
| 90 | oligosaccharide catabolic process (GO:0009313) | 2.27627682 |
| 91 | negative regulation of interleukin-1 production (GO:0032692) | 2.27155198 |
| 92 | positive regulation of type 2 immune response (GO:0002830) | 2.25505710 |
| 93 | regulation of mast cell degranulation (GO:0043304) | 2.25326615 |
| 94 | regulation of activation of Janus kinase activity (GO:0010533) | 2.24698508 |
| 95 | positive regulation of leukocyte degranulation (GO:0043302) | 2.24051388 |
| 96 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.23326493 |
| 97 | DNA deamination (GO:0045006) | 2.23151941 |
| 98 | dendritic cell chemotaxis (GO:0002407) | 2.23091216 |
| 99 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.22260890 |
| 100 | granulocyte activation (GO:0036230) | 2.21999452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.32623088 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.68022280 |
| 3 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.70762642 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.69452394 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.46051865 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.36306852 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 2.28209161 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.20829338 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.00924837 |
| 10 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86333485 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.79420170 |
| 12 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.77533549 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.72750370 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.67660079 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56932014 |
| 16 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55664188 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.54262144 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.47769359 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.41971575 |
| 20 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41221347 |
| 21 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35823248 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.35243126 |
| 23 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.34389762 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34370016 |
| 25 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.31647944 |
| 26 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.29961746 |
| 27 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29439677 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28293365 |
| 29 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.26338346 |
| 30 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.22456974 |
| 31 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.22067224 |
| 32 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20166437 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18185489 |
| 34 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17227063 |
| 35 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15717238 |
| 36 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15425485 |
| 37 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.15160818 |
| 38 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13522756 |
| 39 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13522756 |
| 40 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12238343 |
| 41 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10934006 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.09820749 |
| 43 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.08381285 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.08372351 |
| 45 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.07730994 |
| 46 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06712303 |
| 47 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06359305 |
| 48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.06155470 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05438677 |
| 50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.05205214 |
| 51 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.04513625 |
| 52 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.03788812 |
| 53 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.03349909 |
| 54 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01872423 |
| 55 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00937854 |
| 56 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.00258864 |
| 57 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.99569721 |
| 58 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99028707 |
| 59 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99028707 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98629294 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.97718479 |
| 62 | NCOR_22424771_ChIP-Seq_293T_Human | 0.96504995 |
| 63 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.96285091 |
| 64 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.96172439 |
| 65 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95289679 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.94848478 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94605653 |
| 68 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.94500967 |
| 69 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.93083472 |
| 70 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.92869070 |
| 71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92091681 |
| 72 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91362282 |
| 73 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.91048711 |
| 74 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.90475003 |
| 75 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90269360 |
| 76 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.89136329 |
| 77 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.88968304 |
| 78 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.87148060 |
| 79 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87099228 |
| 80 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.86455167 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.86455167 |
| 82 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.85865973 |
| 83 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.85122064 |
| 84 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.84645242 |
| 85 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.84057109 |
| 86 | TCF4_23295773_ChIP-Seq_U87_Human | 0.83305246 |
| 87 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83298152 |
| 88 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.83272888 |
| 89 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82852328 |
| 90 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.82846801 |
| 91 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.82686591 |
| 92 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82428577 |
| 93 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.82306815 |
| 94 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.82280529 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82256507 |
| 96 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.82206424 |
| 97 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.81637002 |
| 98 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.81633652 |
| 99 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.81172442 |
| 100 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80863709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.26905438 |
| 2 | MP0003724_increased_susceptibility_to | 3.19280540 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 2.84227354 |
| 4 | MP0005670_abnormal_white_adipose | 2.73682635 |
| 5 | MP0005167_abnormal_blood-brain_barrier | 2.70770740 |
| 6 | MP0003195_calcinosis | 2.44175480 |
| 7 | MP0003646_muscle_fatigue | 2.34909305 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.34301597 |
| 9 | MP0000343_altered_response_to | 2.21879657 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.20628791 |
| 11 | MP0005387_immune_system_phenotype | 2.12756559 |
| 12 | MP0001790_abnormal_immune_system | 2.12756559 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.07691788 |
| 14 | MP0000569_abnormal_digit_pigmentation | 2.06008974 |
| 15 | MP0002419_abnormal_innate_immunity | 2.04343922 |
| 16 | MP0003303_peritoneal_inflammation | 1.96553553 |
| 17 | MP0004147_increased_porphyrin_level | 1.94205183 |
| 18 | MP0006082_CNS_inflammation | 1.92932799 |
| 19 | MP0008004_abnormal_stomach_pH | 1.88338844 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.85887742 |
| 21 | MP0001986_abnormal_taste_sensitivity | 1.85854674 |
| 22 | MP0004130_abnormal_muscle_cell | 1.71133191 |
| 23 | MP0005058_abnormal_lysosome_morphology | 1.70953993 |
| 24 | MP0009785_altered_susceptibility_to | 1.67544070 |
| 25 | MP0005025_abnormal_response_to | 1.66336212 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.65650982 |
| 27 | MP0009764_decreased_sensitivity_to | 1.63451222 |
| 28 | MP0005647_abnormal_sex_gland | 1.63042727 |
| 29 | MP0003011_delayed_dark_adaptation | 1.58330897 |
| 30 | MP0004084_abnormal_cardiac_muscle | 1.58059481 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.55896344 |
| 32 | MP0008875_abnormal_xenobiotic_pharmacok | 1.49302231 |
| 33 | MP0002723_abnormal_immune_serum | 1.46682313 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.45268331 |
| 35 | MP0003075_altered_response_to | 1.44649521 |
| 36 | MP0002102_abnormal_ear_morphology | 1.43865235 |
| 37 | MP0004885_abnormal_endolymph | 1.43452990 |
| 38 | MP0001800_abnormal_humoral_immune | 1.40967048 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.39495061 |
| 40 | MP0000685_abnormal_immune_system | 1.37711544 |
| 41 | MP0000015_abnormal_ear_pigmentation | 1.34580520 |
| 42 | MP0009115_abnormal_fat_cell | 1.34207056 |
| 43 | MP0005365_abnormal_bile_salt | 1.29494328 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.28345624 |
| 45 | MP0001819_abnormal_immune_cell | 1.28261064 |
| 46 | MP0002420_abnormal_adaptive_immunity | 1.26479398 |
| 47 | MP0001958_emphysema | 1.25928574 |
| 48 | MP0002405_respiratory_system_inflammati | 1.20440353 |
| 49 | MP0000604_amyloidosis | 1.20107664 |
| 50 | MP0009046_muscle_twitch | 1.19819243 |
| 51 | MP0003436_decreased_susceptibility_to | 1.19547479 |
| 52 | MP0005310_abnormal_salivary_gland | 1.18076251 |
| 53 | MP0004742_abnormal_vestibular_system | 1.17683230 |
| 54 | MP0003828_pulmonary_edema | 1.17591832 |
| 55 | MP0002971_abnormal_brown_adipose | 1.16156644 |
| 56 | MP0005166_decreased_susceptibility_to | 1.14200529 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.13392293 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.12692008 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.11634505 |
| 60 | MP0005551_abnormal_eye_electrophysiolog | 1.07820027 |
| 61 | MP0000371_diluted_coat_color | 1.06532454 |
| 62 | MP0004036_abnormal_muscle_relaxation | 1.05637467 |
| 63 | MP0003279_aneurysm | 1.04031116 |
| 64 | MP0001764_abnormal_homeostasis | 1.03457452 |
| 65 | MP0000230_abnormal_systemic_arterial | 1.01832897 |
| 66 | MP0001727_abnormal_embryo_implantation | 1.01679301 |
| 67 | MP0008469_abnormal_protein_level | 1.00068397 |
| 68 | MP0004215_abnormal_myocardial_fiber | 1.00063650 |
| 69 | MP0005595_abnormal_vascular_smooth | 0.99920112 |
| 70 | MP0004484_altered_response_of | 0.98113276 |
| 71 | MP0005253_abnormal_eye_physiology | 0.97842597 |
| 72 | MP0005379_endocrine/exocrine_gland_phen | 0.96799761 |
| 73 | MP0001545_abnormal_hematopoietic_system | 0.94966699 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 0.94966699 |
| 75 | MP0005410_abnormal_fertilization | 0.93814408 |
| 76 | MP0000249_abnormal_blood_vessel | 0.92027857 |
| 77 | MP0002163_abnormal_gland_morphology | 0.91371156 |
| 78 | MP0001853_heart_inflammation | 0.90442421 |
| 79 | MP0010329_abnormal_lipoprotein_level | 0.88680855 |
| 80 | MP0004142_abnormal_muscle_tone | 0.86178749 |
| 81 | MP0001968_abnormal_touch/_nociception | 0.85361723 |
| 82 | MP0003879_abnormal_hair_cell | 0.84950117 |
| 83 | MP0002638_abnormal_pupillary_reflex | 0.83079120 |
| 84 | MP0004043_abnormal_pH_regulation | 0.83041658 |
| 85 | MP0001486_abnormal_startle_reflex | 0.82397780 |
| 86 | MP0009840_abnormal_foam_cell | 0.82378819 |
| 87 | MP0003183_abnormal_peptide_metabolism | 0.80126759 |
| 88 | MP0003638_abnormal_response/metabolism_ | 0.78540727 |
| 89 | MP0000716_abnormal_immune_system | 0.78156435 |
| 90 | MP0001485_abnormal_pinna_reflex | 0.78056300 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.77359809 |
| 92 | MP0003806_abnormal_nucleotide_metabolis | 0.76245047 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 0.74831924 |
| 94 | MP0003878_abnormal_ear_physiology | 0.74831924 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.74312248 |
| 96 | MP0004145_abnormal_muscle_electrophysio | 0.74189651 |
| 97 | MP0009745_abnormal_behavioral_response | 0.74188525 |
| 98 | MP0002998_abnormal_bone_remodeling | 0.74117371 |
| 99 | MP0002733_abnormal_thermal_nociception | 0.73985660 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.73473498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 7.81426595 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.43772467 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.43772467 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.43772467 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 3.75887852 |
| 6 | Esophageal varix (HP:0002040) | 3.66186694 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.57692516 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 3.21520395 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.20974875 |
| 10 | Congenital sensorineural hearing impairment (HP:0008527) | 3.19573383 |
| 11 | Congenital stationary night blindness (HP:0007642) | 3.18776351 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 3.15499911 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.15499911 |
| 14 | Protuberant abdomen (HP:0001538) | 3.06838294 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.02286596 |
| 16 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.01787578 |
| 17 | Generalized aminoaciduria (HP:0002909) | 2.95743944 |
| 18 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.92405167 |
| 19 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.92223278 |
| 20 | Abolished electroretinogram (ERG) (HP:0000550) | 2.86763581 |
| 21 | Hematochezia (HP:0002573) | 2.86215682 |
| 22 | Recurrent abscess formation (HP:0002722) | 2.82564440 |
| 23 | Agitation (HP:0000713) | 2.77695161 |
| 24 | Congenital hepatic fibrosis (HP:0002612) | 2.74711183 |
| 25 | Mutism (HP:0002300) | 2.72706965 |
| 26 | Spontaneous hematomas (HP:0007420) | 2.71979757 |
| 27 | Adactyly (HP:0009776) | 2.67905046 |
| 28 | Hemoptysis (HP:0002105) | 2.54772205 |
| 29 | Dysostosis multiplex (HP:0000943) | 2.50838557 |
| 30 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.48969743 |
| 31 | Recurrent skin infections (HP:0001581) | 2.41998647 |
| 32 | Abnormality of alanine metabolism (HP:0010916) | 2.37407239 |
| 33 | Hyperalaninemia (HP:0003348) | 2.37407239 |
| 34 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.37407239 |
| 35 | Albinism (HP:0001022) | 2.36329249 |
| 36 | Asymmetric septal hypertrophy (HP:0001670) | 2.35655182 |
| 37 | Recurrent fungal infections (HP:0002841) | 2.31695321 |
| 38 | Stomatitis (HP:0010280) | 2.31079376 |
| 39 | Type II lissencephaly (HP:0007260) | 2.30771182 |
| 40 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.30197890 |
| 41 | Steatorrhea (HP:0002570) | 2.29084556 |
| 42 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.27860246 |
| 43 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.27860246 |
| 44 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.27860246 |
| 45 | Constricted visual fields (HP:0001133) | 2.19471423 |
| 46 | Decreased central vision (HP:0007663) | 2.19237371 |
| 47 | Paralysis (HP:0003470) | 2.17660555 |
| 48 | Molar tooth sign on MRI (HP:0002419) | 2.17325664 |
| 49 | Abnormality of midbrain morphology (HP:0002418) | 2.17325664 |
| 50 | Optic neuritis (HP:0100653) | 2.15082903 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.15082903 |
| 52 | Pendular nystagmus (HP:0012043) | 2.10945828 |
| 53 | Myocardial infarction (HP:0001658) | 2.10735748 |
| 54 | Pancreatic fibrosis (HP:0100732) | 2.09187005 |
| 55 | Portal hypertension (HP:0001409) | 2.07549847 |
| 56 | Disinhibition (HP:0000734) | 2.07231395 |
| 57 | Pancreatic cysts (HP:0001737) | 2.04039497 |
| 58 | Oligomenorrhea (HP:0000876) | 2.01646862 |
| 59 | Hyperventilation (HP:0002883) | 2.01030505 |
| 60 | Widely patent fontanelles and sutures (HP:0004492) | 2.00615272 |
| 61 | Attenuation of retinal blood vessels (HP:0007843) | 1.98654991 |
| 62 | Abnormal drinking behavior (HP:0030082) | 1.97835909 |
| 63 | Polydipsia (HP:0001959) | 1.97835909 |
| 64 | Myositis (HP:0100614) | 1.96870220 |
| 65 | Loss of speech (HP:0002371) | 1.95505274 |
| 66 | Mucopolysacchariduria (HP:0008155) | 1.94484954 |
| 67 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94484954 |
| 68 | Nausea (HP:0002018) | 1.93328370 |
| 69 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.91616448 |
| 70 | Tubular atrophy (HP:0000092) | 1.91521695 |
| 71 | Inability to walk (HP:0002540) | 1.85586643 |
| 72 | Amyloidosis (HP:0011034) | 1.84983730 |
| 73 | Autoimmune thrombocytopenia (HP:0001973) | 1.83639781 |
| 74 | Abnormality of the renal cortex (HP:0011035) | 1.82229959 |
| 75 | Abnormality of the hepatic vasculature (HP:0006707) | 1.81766649 |
| 76 | Polygenic inheritance (HP:0010982) | 1.81708383 |
| 77 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.81674497 |
| 78 | Syncope (HP:0001279) | 1.79656555 |
| 79 | Cheilitis (HP:0100825) | 1.79541124 |
| 80 | Polyphagia (HP:0002591) | 1.79256440 |
| 81 | Upper motor neuron abnormality (HP:0002127) | 1.77253797 |
| 82 | Orchitis (HP:0100796) | 1.77027475 |
| 83 | Abnormality of the periventricular white matter (HP:0002518) | 1.76506721 |
| 84 | Progressive inability to walk (HP:0002505) | 1.74228635 |
| 85 | Frequent falls (HP:0002359) | 1.73697113 |
| 86 | True hermaphroditism (HP:0010459) | 1.73361023 |
| 87 | Progressive visual loss (HP:0000529) | 1.73195604 |
| 88 | Hypercholesterolemia (HP:0003124) | 1.72375139 |
| 89 | Mediastinal lymphadenopathy (HP:0100721) | 1.70902653 |
| 90 | Pachygyria (HP:0001302) | 1.69625595 |
| 91 | 3-Methylglutaconic aciduria (HP:0003535) | 1.67394114 |
| 92 | Agnosia (HP:0010524) | 1.67250614 |
| 93 | Pustule (HP:0200039) | 1.66836023 |
| 94 | Hemiplegia (HP:0002301) | 1.65274347 |
| 95 | Acute necrotizing encephalopathy (HP:0006965) | 1.65127763 |
| 96 | Hepatosplenomegaly (HP:0001433) | 1.64900447 |
| 97 | Macular degeneration (HP:0000608) | 1.62730310 |
| 98 | Abnormal urine output (HP:0012590) | 1.62484929 |
| 99 | Pulmonary embolism (HP:0002204) | 1.60403109 |
| 100 | Cerebral hemorrhage (HP:0001342) | 1.60001211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ADRBK2 | 3.24612745 |
| 2 | TIE1 | 3.10181771 |
| 3 | FRK | 3.05032838 |
| 4 | BLK | 2.99775930 |
| 5 | GRK7 | 2.78789869 |
| 6 | PINK1 | 2.30104904 |
| 7 | DAPK2 | 2.27404964 |
| 8 | TYK2 | 1.89924005 |
| 9 | ACVR1B | 1.87382897 |
| 10 | CAMKK2 | 1.83757214 |
| 11 | WNK4 | 1.82788543 |
| 12 | OBSCN | 1.78377552 |
| 13 | RIPK4 | 1.70271571 |
| 14 | PIK3CG | 1.70236455 |
| 15 | INSRR | 1.68207340 |
| 16 | CAMK1D | 1.67116148 |
| 17 | TAOK3 | 1.63995313 |
| 18 | FES | 1.63435122 |
| 19 | TEC | 1.57910167 |
| 20 | CSF1R | 1.56796388 |
| 21 | ITK | 1.50176612 |
| 22 | GRK1 | 1.42829857 |
| 23 | JAK3 | 1.41175557 |
| 24 | CSK | 1.39027801 |
| 25 | CAMK1G | 1.36567941 |
| 26 | SYK | 1.35354151 |
| 27 | TTN | 1.34751581 |
| 28 | BMPR1B | 1.31556065 |
| 29 | PTK2B | 1.25949950 |
| 30 | MAP4K2 | 1.23777172 |
| 31 | NEK9 | 1.19212854 |
| 32 | OXSR1 | 1.10584627 |
| 33 | MAP3K14 | 1.09645293 |
| 34 | SGK2 | 1.07946809 |
| 35 | FGR | 1.07062260 |
| 36 | PIM2 | 1.06629729 |
| 37 | KDR | 1.03510551 |
| 38 | IKBKB | 1.03007245 |
| 39 | TGFBR2 | 1.00437968 |
| 40 | BTK | 1.00170904 |
| 41 | RPS6KA2 | 0.99564223 |
| 42 | PRKCQ | 0.96141754 |
| 43 | WNK3 | 0.94702700 |
| 44 | STK39 | 0.93699849 |
| 45 | PHKG2 | 0.92745746 |
| 46 | PHKG1 | 0.92745746 |
| 47 | TXK | 0.92467752 |
| 48 | KIT | 0.91815005 |
| 49 | MAP2K3 | 0.89797920 |
| 50 | CAMKK1 | 0.89729934 |
| 51 | MAPK13 | 0.85576492 |
| 52 | ZAK | 0.85061344 |
| 53 | LYN | 0.84301346 |
| 54 | SGK3 | 0.83014629 |
| 55 | ADRBK1 | 0.82143519 |
| 56 | MAP3K13 | 0.81749311 |
| 57 | TRPM7 | 0.81072345 |
| 58 | MAPKAPK3 | 0.80971544 |
| 59 | RPS6KA6 | 0.80416922 |
| 60 | NTRK3 | 0.76427149 |
| 61 | PDK1 | 0.76226909 |
| 62 | EPHB1 | 0.75715250 |
| 63 | HCK | 0.75694821 |
| 64 | MAP2K6 | 0.74575571 |
| 65 | MAPK12 | 0.72873805 |
| 66 | SGK223 | 0.72645308 |
| 67 | SGK494 | 0.72645308 |
| 68 | LCK | 0.72105058 |
| 69 | CDC42BPA | 0.69479429 |
| 70 | PDK2 | 0.69303887 |
| 71 | CAMK1 | 0.67343573 |
| 72 | MAP4K1 | 0.64897061 |
| 73 | IRAK1 | 0.62949581 |
| 74 | JAK2 | 0.62490253 |
| 75 | RPS6KL1 | 0.62041572 |
| 76 | RPS6KC1 | 0.62041572 |
| 77 | MATK | 0.60618689 |
| 78 | NUAK1 | 0.59383692 |
| 79 | PDPK1 | 0.58418880 |
| 80 | PNCK | 0.56519757 |
| 81 | MOS | 0.55267325 |
| 82 | NTRK2 | 0.55092382 |
| 83 | PRKG2 | 0.54150311 |
| 84 | ABL2 | 0.53794643 |
| 85 | BCKDK | 0.53686914 |
| 86 | PRKG1 | 0.52280660 |
| 87 | PRKCE | 0.52226533 |
| 88 | PRKACA | 0.51757436 |
| 89 | ABL1 | 0.47902510 |
| 90 | TLK1 | 0.47747674 |
| 91 | STK11 | 0.47404710 |
| 92 | TRIM28 | 0.46769558 |
| 93 | PRKAA2 | 0.46702492 |
| 94 | MARK3 | 0.46548131 |
| 95 | ZAP70 | 0.45855944 |
| 96 | PKN1 | 0.45777119 |
| 97 | FER | 0.45460373 |
| 98 | PRKACG | 0.43214163 |
| 99 | MAP3K11 | 0.42689208 |
| 100 | DYRK2 | 0.42402628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 3.56371543 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.15518639 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.14719947 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.94511167 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.71979401 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.60962759 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 2.56354782 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.54117923 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.53407132 |
| 10 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.41028206 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.26801202 |
| 12 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.22203556 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.10626402 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 2.07550594 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 2.07413084 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.89250935 |
| 17 | Phagosome_Homo sapiens_hsa04145 | 1.83702184 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.74382631 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.65593600 |
| 20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.63203622 |
| 21 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.60540742 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.49320522 |
| 23 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.42389461 |
| 24 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.35399911 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31818648 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.28499180 |
| 27 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23574666 |
| 28 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.21392849 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.17022589 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16245614 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.14772292 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.12897209 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11781038 |
| 34 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.10996165 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09232308 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.08799266 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08422355 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.02371627 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 1.01628752 |
| 40 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.98860059 |
| 41 | Morphine addiction_Homo sapiens_hsa05032 | 0.97207283 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94186078 |
| 43 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.92790445 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89560468 |
| 45 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.88165289 |
| 46 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.85102979 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 0.84365728 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81335300 |
| 49 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.77597993 |
| 50 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.77021070 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75910182 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74279504 |
| 53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.72919099 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71997966 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.71604305 |
| 56 | Malaria_Homo sapiens_hsa05144 | 0.71194657 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.71023242 |
| 58 | Legionellosis_Homo sapiens_hsa05134 | 0.67719224 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66956790 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66460308 |
| 61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65837894 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.64878271 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63454475 |
| 64 | GABAergic synapse_Homo sapiens_hsa04727 | 0.63002797 |
| 65 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62662855 |
| 66 | Renin secretion_Homo sapiens_hsa04924 | 0.62568069 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62553571 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61899597 |
| 69 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60726043 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 0.59082995 |
| 71 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.58210901 |
| 72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56887890 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53686274 |
| 74 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.52029927 |
| 75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.50863979 |
| 76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49397087 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.49196368 |
| 78 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.48076000 |
| 79 | Olfactory transduction_Homo sapiens_hsa04740 | 0.47784731 |
| 80 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.46955235 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45057176 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.44447644 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43906453 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.39894499 |
| 85 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.38862296 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36755285 |
| 87 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.34162362 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33176009 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30993932 |
| 90 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.30195653 |
| 91 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.28980731 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.27095242 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.26866944 |
| 94 | Huntingtons disease_Homo sapiens_hsa05016 | 0.26238867 |
| 95 | Measles_Homo sapiens_hsa05162 | 0.26202566 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.25925819 |
| 97 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.25567596 |
| 98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.25078311 |
| 99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.24517495 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.23903515 |

